Prevalence of hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma

The purpose of this study was to determine the prevalence of chronic hepatitis virus infection [HCV] in patients with B-cell non-Hodgkin's lymphoma [B-cell NHL]. This controlled, cross sectional study included 30 patients with B-cell non-Hodgkin's lymphoma [B-cell NHL], 30 patients with malignant hematologic neoplesia other than B-cell NHL [control group I] and 30 patients randomly selected from general medical patients and healthy blood donors with non-malignant conditions [control group II]. All study populations were tested for antibodies to HCV by using a second-generation enzyme-linked immunosorbent assay [Anti-HCV EIA II]. Positive and indeterminate results were subjected to confirmatory testing using RLBA-hepatitis C virus [recombinant-based immunoblot assay- RIBA II]. Hepatitis C virus RNA was detected by a reverse transcription polymerase chain reaction [RT-PCR] assay. The results of this study indicated a higher prevalence of hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma than in the control groups. The prevalence of hepatitis C virus infection in the two control groups, in turn, seems to fall within the estimated prevalence in the general population. These results raise the possibility for a subslantial role of chronic HCV infection in the aetiopathology of non Hodgkin's lymphoma

Epidemiological factors in relation to histopathology of chronic hepatitis C infection

This study was designed to find the relation between the histopathological features of chronic hepatitis C infection and epidemiological factors. We reviewed the records of three hundred patients from Bristol Royal Infirmary, Bristol, UK. The mean age of the patients was 42.5 +/- 10.6 years. 205 patients [68.3%] were males and 95 [31.7%] were females. The mean duration of infection was 15.1 +/- 8.3 years. The most frequent risk factor was IVDU. 62.7% of the patients were asymptomatic and 73.7% had no clinical signs of chronic liver disease. All patients were positive for hepatitis C antibody and PCR. Histopathological grading and staging [modified Ishak HAI] were: normal liver in 3 cases [1%], minimal chronic hepatitis in 50 cases [16.8%], mild chronic hepatitis in 159 cases [53.5%], moderate chronic hepatitis in 81 cases [27.3%] and severe chronic hepatitis in 4 cases [1.3%]. Three cases [1%] were hepatocellular carcinoma. There was no significant gender difference in respect of grade or stage of chronic hepatitis C infection [P>0.05]. Patients less than 40 years old and those with duration of infection less than 20 years were more frequent in Stages 1 and 2 while patients aged 40 and above and those with duration of infection of 20 years and above were more frequent in stages 5 and 6 fibrosis [P<0.001]. Other histological features also present included steatosis in 68 cases [22.9%], lymphoid follicles / aggregates in 27 cases [9.1%] and bile duct proliferation in 17 cases [5.7%]. These 3 features were more often encountered in mild chronic hepatitis. However bile duct proliferation was more common among patients with cirrhosis. We conclude that more than half of chronic hepatitis C patients presented with mild histological features. The duration of infection and the patient's age were associated with liver fibrosis. Steatosis, lymphoid follicles and bile duct proliferation were present in association with chronic hepatitis C in a proportion of cases

Prevalence of hepatitis c virus infection in patients with B-cell non-Hodgkin's lymphoma

This controlled, cross-sectional study included 30 patients with B-cell non-Hodgkin's lymphoma [B-cell NHL], 30 patients with malignant hematologic neoplesia other than B-cell NHL [control group I] and 30 patients randomly selected from general medical patients and healthy blood donors with non-malignant conditions [control group II]. All study populations were tested for antibodies to HCV by using a second-generation enzyme-linked immunosorbent assay [anti-HCV EIA II]. Positive and indeterminate results were subjected to confirmatory testing using RIBA-hepatitis C virus [recombinant-based immunoblot assay-RIBA II]. Hepatitis C virus RNA was detected by a reverse-transcription polymerase chain reaction [RT-PCR] assay. The results revealed that infection with HCV was detected in nine patients with B-cell non-Hodgkin's lymphoma compared with two of 30 patients in control group I and one of 30 patients in control group II. All the three groups were matched as regarding age, sex and risk factors for hepatitis C virus infection. Patients with B-cell NHL who were HCV positive and HCV negative did not differ significantly with respect to the prevalence of low-grade [22.3% and 28.6%], or intermediate to high-grade lymphoma [77.7% and 71.4%]. In conclusion, the results of this study indicated a higher prevalence of hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma than in the control groups. The prevalence of hepatitis C virus infection in the two control groups, in turn, seems to fall within the estimated prevalence in the general population

Ultrasonographic patterns of splenic and hepatic lymphoma

Twenty-five cases of lymphoma were studied, only 20 cases had splenic and/or hepatic infiltration as detected by the examination of splenic aspiration and liver biopsy, of which two cases had Hodgkin's disease and 18 had non-Hodgkin's lymphoma. The main ultrasonographic pattern of the spleen was the focal lesions observed in 14 cases, either hypoechoic in 11 or target lesions in three cases and the other pattern, which is the diffuse low echoes, was observed in six cases which could suggest lymphomatous infiltration of the spleen. The ultrasonographic pattern of the liver showed focal lesions in only three cases and diffuse low echoes in the remaining 17 cases. These patterns are nonspecific and may be difficult to distinguish from other forms of hepatic diseases or malignant infiltration

Liver large cell dysplasia: a possible premalignant condition: a case report

There is still a debate about the role of liver cell dysplasia as a premalignant lesion. A 54 years old Egyptian man with chronic, liver disease was admitted for evaluation of his liver condition. He was diagnosed as liver cirrhosis, portal hypertension and hepatocellular failure. His serum hepatitis B surface antigen was positive and alpha fetoprotein [AFP] level was 200 ng/ml. The histopathological examination of liver biopsy showed liver large cell dysplasia [LCD], which was identified in all histological stenosis on lever power examination. Hepatitis B surface antigen was identified in hepatocytes by orcein stain. It was suggested that cirrhotic patient with liver large cell dysplasia, age above 50 years, hepatitis B surface antigen positive, advanced liver disease and raised AFP level could be major predictors of neoplastic transformation of HCC. Therefore, regular assessment by hepatic ultrasonography and AFP may identify early hepatocellular carcinoma